Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196356670> ?p ?o ?g. }
- W3196356670 endingPage "4521" @default.
- W3196356670 startingPage "4521" @default.
- W3196356670 abstract "Reprogramming the tumor stroma is an emerging approach to circumventing the challenges of conventional cancer therapies. This strategy, however, is hampered by the lack of a specific molecular target. We previously reported that stromal fibroblasts (FBs) with high expression of CD36 could be utilized for this purpose. These studies are now expanded to identify the secreted factors responsible for tumor suppression. Methodologies included 3D colonies, fluorescent microscopy coupled with quantitative techniques, proteomics profiling, and bioinformatics analysis. The results indicated that the conditioned medium (CM) of the CD36+ FBs caused growth suppression via apoptosis in the triple-negative cell lines of MDA-MB-231, BT549, and Hs578T, but not in the ERBB2+ SKBR3. Following the proteomics and bioinformatic analysis of the CM of CD36+ versus CD36− FBs, we determined KLF10 as one of the transcription factors responsible for growth suppression. We also identified FBLN1, SLIT3, and PENK as active ligands, where their minimum effective concentrations were determined. Finally, in MDA-MB-231, we showed that a mixture of FBLN1, SLIT3, and PENK could induce an amount of growth suppression similar to the CM of CD36+ FBs. In conclusion, our findings suggest that these ligands, secreted by CD36+ FBs, can be targeted for breast cancer treatment." @default.
- W3196356670 created "2021-09-13" @default.
- W3196356670 creator A5050929278 @default.
- W3196356670 creator A5053749724 @default.
- W3196356670 creator A5054315462 @default.
- W3196356670 creator A5054902187 @default.
- W3196356670 creator A5055507176 @default.
- W3196356670 creator A5061810267 @default.
- W3196356670 creator A5076518660 @default.
- W3196356670 creator A5086345137 @default.
- W3196356670 date "2021-09-08" @default.
- W3196356670 modified "2023-10-07" @default.
- W3196356670 title "Protein Ligands in the Secretome of CD36+ Fibroblasts Induce Growth Suppression in a Subset of Breast Cancer Cell Lines" @default.
- W3196356670 cites W1016059894 @default.
- W3196356670 cites W1514397065 @default.
- W3196356670 cites W1536642770 @default.
- W3196356670 cites W1548779692 @default.
- W3196356670 cites W1572890328 @default.
- W3196356670 cites W1572927059 @default.
- W3196356670 cites W1933245301 @default.
- W3196356670 cites W1950988583 @default.
- W3196356670 cites W1967293289 @default.
- W3196356670 cites W1976421363 @default.
- W3196356670 cites W1994162941 @default.
- W3196356670 cites W1998741786 @default.
- W3196356670 cites W2021618744 @default.
- W3196356670 cites W2031087917 @default.
- W3196356670 cites W2031139506 @default.
- W3196356670 cites W2032390346 @default.
- W3196356670 cites W2035315325 @default.
- W3196356670 cites W2041399392 @default.
- W3196356670 cites W2043013160 @default.
- W3196356670 cites W2052619363 @default.
- W3196356670 cites W2054823277 @default.
- W3196356670 cites W2054922344 @default.
- W3196356670 cites W2072155339 @default.
- W3196356670 cites W2078374322 @default.
- W3196356670 cites W2082496903 @default.
- W3196356670 cites W2087548571 @default.
- W3196356670 cites W2102577577 @default.
- W3196356670 cites W2113965971 @default.
- W3196356670 cites W2127362646 @default.
- W3196356670 cites W2128891846 @default.
- W3196356670 cites W2129968911 @default.
- W3196356670 cites W2131310023 @default.
- W3196356670 cites W2132843604 @default.
- W3196356670 cites W2141937355 @default.
- W3196356670 cites W2146971577 @default.
- W3196356670 cites W2174026431 @default.
- W3196356670 cites W2307244832 @default.
- W3196356670 cites W2347175105 @default.
- W3196356670 cites W2407822856 @default.
- W3196356670 cites W2441417470 @default.
- W3196356670 cites W2465700327 @default.
- W3196356670 cites W2470164261 @default.
- W3196356670 cites W2593838139 @default.
- W3196356670 cites W2804726266 @default.
- W3196356670 cites W2804801760 @default.
- W3196356670 cites W2888792426 @default.
- W3196356670 cites W2952990620 @default.
- W3196356670 cites W2959308106 @default.
- W3196356670 cites W2964245665 @default.
- W3196356670 cites W2964508022 @default.
- W3196356670 cites W2970289072 @default.
- W3196356670 cites W2980576786 @default.
- W3196356670 cites W2989380501 @default.
- W3196356670 cites W2996419733 @default.
- W3196356670 cites W3003058300 @default.
- W3196356670 cites W3012399185 @default.
- W3196356670 cites W3029176993 @default.
- W3196356670 cites W3040358167 @default.
- W3196356670 cites W3118578071 @default.
- W3196356670 cites W3165203530 @default.
- W3196356670 cites W3176842523 @default.
- W3196356670 doi "https://doi.org/10.3390/cancers13184521" @default.
- W3196356670 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8469330" @default.
- W3196356670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572749" @default.
- W3196356670 hasPublicationYear "2021" @default.
- W3196356670 type Work @default.
- W3196356670 sameAs 3196356670 @default.
- W3196356670 citedByCount "8" @default.
- W3196356670 countsByYear W31963566702022 @default.
- W3196356670 countsByYear W31963566702023 @default.
- W3196356670 crossrefType "journal-article" @default.
- W3196356670 hasAuthorship W3196356670A5050929278 @default.
- W3196356670 hasAuthorship W3196356670A5053749724 @default.
- W3196356670 hasAuthorship W3196356670A5054315462 @default.
- W3196356670 hasAuthorship W3196356670A5054902187 @default.
- W3196356670 hasAuthorship W3196356670A5055507176 @default.
- W3196356670 hasAuthorship W3196356670A5061810267 @default.
- W3196356670 hasAuthorship W3196356670A5076518660 @default.
- W3196356670 hasAuthorship W3196356670A5086345137 @default.
- W3196356670 hasBestOaLocation W31963566701 @default.
- W3196356670 hasConcept C104317684 @default.
- W3196356670 hasConcept C121608353 @default.
- W3196356670 hasConcept C16930146 @default.
- W3196356670 hasConcept C170493617 @default.
- W3196356670 hasConcept C185592680 @default.